ESC Congress 2026

Richmond Pharmacology is pleased to attend the ESC Congress 2026 in Munich, Germany, on 28- 31 August 2026.

This flagship global event brings together cardiology leaders, researchers, and innovators to advance cardiovascular medicine through groundbreaking science, clinical insights, and collaborative solutions.

Representing Richmond Pharmacology

• Jörg Taubel, Chief Executive Officer

We look forward to connecting with attendees to discuss Richmond’s expertise in:

• Innovations in cardiovascular drug development

• Clinical trial design for complex cardiac conditions

• Regulatory pathways for novel therapies

• Patient-centric approaches and recruitment strategies

• Collaboration between academia, industry, and regulators

Connect With Us

If you are attending ESC Congress 2026 and would like to explore partnership or development opportunities email us at:

📧 fasteranswers@richmondpharmacology.com

‍